63558-65-6Relevant articles and documents
4-Anilino-pyrimidine, novel aldosterone synthase (CYP11B2) inhibitors bearing pyrimidine structures
Meguro, Masaki,Miyauchi, Satoru,Kanao, Yukiko,Naito, Satoru,Suzuki, Kanae,Inoue, Shinichi,Yamada, Keisuke,Homma, Tsuyoshi,Chiba, Kiyoshi,Nara, Futoshi,Furuzono, Shinji
, p. 1902 - 1906 (2017)
2,2,2-Trifluoro-1-{4-[(4-fluorophenyl)amino]pyrimidin-5-yl}-1-[1-(methylsulfonyl)piperidin-4-yl]ethanol 1 was identified as a novel potent aldosterone synthase inhibitor. Despite large species differences, compound 1 inhibits both human and rodent CYP11B2 in a nano-molar range.
Hetero-aromatic compound and its use in medicine
-
Paragraph 0857; 0860-0862, (2019/07/04)
The invention provides a hetero-aromatic compound or a stereisomer, geometric isomer, tautomer, despinner, nitrogen oxide, hydrate, solvate, metabolite, metabolism precursor and pharmaceutically acceptable salt or prodrug thereof, which is used for treating proliferative diseases. The invention also discloses a pharmaceutical composition containing the compound and an application of the compound or pharmaceutical composition thereof in preparation of a medicine for treating proliferative diseases.
Aurora kinase modulators and method of use
-
Page/Page column 47, (2008/06/13)
The present invention relates to chemical compounds having a general formula I wherein A1, A2, C1, C2, D, L1, L2, Z and R1- are defined herein, and synthetic intermediates, which